Peripheral biomarkers revisited: Integrative profiling of peripheral samples for psychiatric research

Biological Psychiatry

Volumn 75, Issue 12, 2014, Pages 920-928

  Hayashi Takagi, Akiko ^a,b   Vawter, Marquis P ^c   Iwamoto, Kazuya ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Biomarker; diagnostic support; functional assay; omics; peripheral sample; tailor made therapy

Indexed keywords

BIOLOGICAL MARKER; PROTEIN; PROTEOME; TRANSCRIPTOME;

APOPTOSIS; BLOOD; BLOOD CELL; CELL CYCLE; CENTRAL NERVOUS SYSTEM; DNA METHYLATION; EPITHELIUM CELL; ERYTHROCYTE; FIBROBLAST; GENOMICS; GENOTYPE; HUMAN; IMMUNE SYSTEM; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE; MEDICAL RESEARCH; METABOLITE; METABOLOME; NEUROTRANSMISSION; OLFACTORY EPITHELIUM; PLURIPOTENT STEM CELL; PRIMARY CELL; PRIORITY JOURNAL; PSYCHIATRY; REVIEW; SCHIZOPHRENIA; THROMBOCYTE; BRAIN; EPIGENETICS; MENTAL DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SKIN;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; BLOOD CELLS; BRAIN; EPIGENOMICS; HUMANS; MENTAL DISORDERS; METABOLOME; PROTEOME; PSYCHIATRY; REPRODUCIBILITY OF RESULTS; SKIN; TRANSCRIPTOME;

EID: 84901304269     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.09.035     Document Type: Review

References (86)

1. J.Z. Li, M.P. Vawter, D.M. Walsh, H. Tomita, S.J. Evans, and P.V. Choudary et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions Hum Mol Genet 13 2004 609 616
2. K. Hashimoto, A. Sawa, and M. Iyo Increased levels of glutamate in brains from patients with mood disorders Biol Psychiatry 62 2007 1310 1316
3. R. Dolmetsch, and D.H. Geschwind The human brain in a dish: The promise of iPSC-derived neurons Cell 145 2011 831 834
4. K.J. Brennand, A. Simone, J. Jou, C. Gelboin-Burkhart, N. Tran, and S. Sangar et al. Modelling schizophrenia using human induced pluripotent stem cells Nature 473 2011 221 225
5. P.F. Sullivan, M.J. Daly, and M. O'Donovan Genetic architectures of psychiatric disorders: The emerging picture and its implications Nat Rev Genet 13 2012 537 551
6. P.F. Sullivan, C. Fan, and C.M. Perou Evaluating the comparability of gene expression in blood and brain Am J Med Genet B Neuropsychiatr Genet 141B 2006 261 268
7. V. Emilsson, G. Thorleifsson, B. Zhang, A.S. Leonardson, F. Zink, and J. Zhu et al. Genetics of gene expression and its effect on disease Nature 452 2008 423 428
8. B. Rollins, M.V. Martin, L. Morgan, and M.P. Vawter Analysis of whole genome biomarker expression in blood and brain Am J Med Genet B Neuropsychiatr Genet 153B 2010 919 936
9. D.G. Hernandez, M.A. Nalls, M. Moore, S. Chong, A. Dillman, and D. Trabzuni et al. Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain Neurobiol Dis 47 2012 20 28
10. I. Voineagu Gene expression studies in autism: Moving from the genome to the transcriptome and beyond Neurobiol Dis 45 2012 69 75
11. M.N. Davies, M. Volta, R. Pidsley, K. Lunnon, A. Dixit, and S. Lovestone et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood Genome Biol 13 2012 R43
12. S. Horvath, Y. Zhang, P. Langfelder, R.S. Kahn, M.P. Boks, and K. van Eijk et al. Aging effects on DNA methylation modules in human brain and blood tissue Genome Biol 13 2012 R97
13. S.J. Glatt, I.P. Everall, W.S. Kremen, J. Corbeil, R. Sasik, and N. Khanlou et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia Proc Natl Acad Sci U S A 102 2005 15533 15538
14. H. Nawa, M. Takahashi, and P.H. Patterson Cytokine and growth factor involvement in schizophrenia - support for the developmental model Mol Psychiatry 5 2000 594 603
15. L.M. Boulanger Immune proteins in brain development and synaptic plasticity Neuron 64 2009 93 109
16. A. Gladkevich, H.F. Kauffman, and J. Korf Lymphocytes as a neural probe: Potential for studying psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry 28 2004 559 576
17. C.N. Morrell, H. Sun, M. Ikeda, J.C. Beique, A.M. Swaim, and E. Mason et al. Glutamate mediates platelet activation through the AMPA receptor J Exp Med 205 2008 575 584
18. D. Ben-Shachar, O. Bonne, R. Chisin, E. Klein, H. Lester, and J. Aharon-Peretz et al. Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study Prog Neuropsychopharmacol Biol Psychiatry 31 2007 807 813
19. N. Dror, E. Klein, R. Karry, A. Sheinkman, Z. Kirsh, and M. Mazor et al. State-dependent alterations in mitochondrial complex I activity in platelets: A potential peripheral marker for schizophrenia Mol Psychiatry 7 2002 995 1001
20. J.F. Padin, M.A. Rodriguez, E. Dominguez, I.G. Dopeso-Reyes, M. Buceta, and E. Cano et al. Parallel regulation by olanzapine of the patterns of expression of 5-HT2A and D3 receptors in rat central nervous system and blood cells Neuropharmacology 51 2006 923 932
21. C. Thery Exosomes: Secreted vesicles and intercellular communications F1000 Biol Rep 3 2011 15
22. P.R. Glade, and N.G. Beratis Long-term lymphoid cell lines in the study of human genetics Prog Med Genet 1 1976 1 48
23. A.S. Mello, M.G. Burin, K. Michellin, M. Viapiana, R. Giugliani, J.C. Coelho, and M.E. Bauer Epstein-Barr virus-induced transformation of B cells for the diagnosis of genetic metabolic disorders - enumerative conditions for cryopreservation Cell Prolif 39 2006 29 36
24. A. Hayashi, T. Kasahara, M. Kametani, T. Toyota, T. Yoshikawa, and T. Kato Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder Int J Neuropsychopharmacol 12 2009 33 43
25. Y. Sei, R. Ren-Patterson, Z. Li, E.M. Tunbridge, M.F. Egan, B.S. Kolachana, and D.R. Weinberger Neuregulin1-induced cell migration is impaired in schizophrenia: Association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms Mol Psychiatry 12 2007 946 957
26. S.P. Mahadik, and S. Mukherjee Cultured skin fibroblasts as a cell model for investigating schizophrenia J Psychiatr Res 30 1996 421 439
27. D. Fekkes, L. Pepplinkhuizen, and J. Bruinvels Changes in serine metabolism by a serum factor present in a group of episodic psychotic patients Biol Psychiatry 30 1991 966 972
28. S.M. Stahl Peripheral models for the study of neurotransmitter receptors in man Psychopharmacol Bull 21 1985 663 671
29. Q. Chen, and B.N. Ames Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells Proc Natl Acad Sci U S A 91 1994 4130 4134
30. L. Flyckt, N. Venizelos, G. Edman, L. Bjerkenstedt, L. Hagenfeldt, and F.A. Wiesel Aberrant tyrosine transport across the cell membrane in patients with schizophrenia Arch Gen Psychiatry 58 2001 953 958
31. V.S. Catts, S.V. Catts, J.J. McGrath, F. Feron, D. McLean, E.J. Coulson, and L.H. Lutze-Mann Apoptosis and schizophrenia: A pilot study based on dermal fibroblast cell lines Schizophr Res 84 2006 20 28
32. M.J. Ziller, H. Gu, F. Muller, J. Donaghey, L.T. Tsai, and O. Kohlbacher et al. Charting a dynamic DNA methylation landscape of the human genome Nature 500 2013 477 481
33. A.P. Feinberg Phenotypic plasticity and the epigenetics of human disease Nature 447 2007 433 440
34. N. Tsankova, W. Renthal, A. Kumar, and E.J. Nestler Epigenetic regulation in psychiatric disorders Nat Rev Neurosci 8 2007 355 367
35. A. Petronis Epigenetics as a unifying principle in the aetiology of complex traits and diseases Nature 465 2010 721 727
36. M. Nishioka, M. Bundo, K. Kasai, and K. Iwamoto DNA methylation in schizophrenia: Progress and challenges of epigenetic studies Genome Med 4 2012 96
37. E.L. Dempster, R. Pidsley, L.C. Schalkwyk, S. Owens, A. Georgiades, and F. Kane et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder Hum Mol Genet 20 2011 4786 4796
38. Z. Kaminsky, M. Tochigi, P. Jia, M. Pal, J. Mill, and A. Kwan et al. A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder Mol Psychiatry 17 2012 728 740
39. P.A. Melas, M. Rogdaki, U. Osby, M. Schalling, C. Lavebratt, and T.J. Ekstrom Epigenetic aberrations in leukocytes of patients with schizophrenia: Association of global DNA methylation with antipsychotic drug treatment and disease onset FASEB J 26 2012 2712 2718
40. M. Shimabukuro, T. Sasaki, A. Imamura, T. Tsujita, C. Fuke, and T. Umekage et al. Global hypomethylation of peripheral leukocyte DNA in male patients with schizophrenia: A potential link between epigenetics and schizophrenia J Psychiatr Res 41 2007 1042 1046
41. R.Z. Chen, U. Pettersson, C. Beard, L. Jackson-Grusby, and R. Jaenisch DNA hypomethylation leads to elevated mutation rates Nature 395 1998 89 93
42. M.T. Wayland, and S. Bahn Reproducibility of microarray studies: Concordance of current analysis methods Prog Brain Res 158 2006 109 125
43. K. Mirnics, P. Levitt, and D.A. Lewis Critical appraisal of DNA microarrays in psychiatric genomics Biol Psychiatry 60 2006 163 176
44. P.A. Sequeira, M.V. Martin, and M.P. Vawter The first decade and beyond of transcriptional profiling in schizophrenia Neurobiol Dis 45 2012 23 36
45. M.T. Tsuang, N. Nossova, T. Yager, M.M. Tsuang, S.C. Guo, and K.G. Shyu et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: A preliminary report Am J Med Genet B Neuropsychiatr Genet 133B 2005 1 5
46. M. Takahashi, H. Hayashi, Y. Watanabe, K. Sawamura, N. Fukui, and J. Watanabe et al. Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures Schizophr Res 119 2010 210 218
47. Y. Yao, J. Schroder, and H. Karlsson Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia J Psychiatr Res 42 2008 639 643
48. S.J. Glatt, W.S. Stone, N. Nossova, C.C. Liew, L.J. Seidman, and M.T. Tsuang Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives Am J Med Genet B Neuropsychiatr Genet 156B 2011 869 887
49. M.P. Vawter, E. Ferran, B. Galke, K. Cooper, W.E. Bunney, and W. Byerley Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree Schizophr Res 67 2004 41 52
50. T.L. Petryshen, F.A. Middleton, A. Kirby, K.A. Aldinger, S. Purcell, and A.R. Tahl et al. Support for involvement of neuregulin 1 in schizophrenia pathophysiology Mol Psychiatry 10 2005 366 374 328
51. T.L. Petryshen, F.A. Middleton, A.R. Tahl, G.N. Rockwell, S. Purcell, and K.A. Aldinger et al. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia Mol Psychiatry 10 2005 1074 1088 1057
52. S. Yang, H.P. Van Dongen, K. Wang, W. Berrettini, and M. Bucan Assessment of circadian function in fibroblasts of patients with bipolar disorder Mol Psychiatry 14 2009 143 155
53. J.T. Huang, L. Wang, S. Prabakaran, M. Wengenroth, H.E. Lockstone, and D. Koethe et al. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues Mol Psychiatry 13 2008 1118 1128
54. M. Herberth, D. Koethe, Y. Levin, E. Schwarz, N.D. Krzyszton, and S. Schoeffmann et al. Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival Proteomics 11 2011 94 105
55. Y. Levin, L. Wang, E. Schwarz, D. Koethe, F.M. Leweke, and S. Bahn Global proteomic profiling reveals altered proteomic signature in schizophrenia serum Mol Psychiatry 15 2010 1088 1100
56. D. Martins-de-Souza, P.C. Guest, N. Vanattou-Saifoudine, L.W. Harris, and S. Bahn Proteomic technologies for biomarker studies in psychiatry: Advances and needs Int Rev Neurobiol 101 2011 65 94
57. J.A. English, K. Pennington, M.J. Dunn, and D.R. Cotter The neuroproteomics of schizophrenia Biol Psychiatry 69 2011 163 172
58. R.M. Mangano, and R. Schwarcz The human platelet as a model for the glutamatergic neuron: Platelet uptake of L-glutamate J Neurochem 36 1981 1067 1076
59. P.C. Baier, J.M. Koch, M. Seeck-Hirschner, K. Ohlmeyer, S. Wilms, J.B. Aldenhoff, and D. Hinze-Selch A flow-cytometric method to investigate glutamate-receptor-sensitivity in whole blood platelets - results from healthy controls and patients with schizophrenia J Psychiatr Res 43 2009 585 591
60. L.S. Pilowsky, R.A. Bressan, J.M. Stone, K. Erlandsson, R.S. Mulligan, J.H. Krystal, and P.J. Ell First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients Mol Psychiatry 11 2006 118 119
61. A. Hayashi-Takagi, and A. Sawa Disturbed synaptic connectivity in schizophrenia: Convergence of genetic risk factors during neurodevelopment Brain Res Bull 83 2010 140 146
62. M.C. Ryan, P. Collins, and J.H. Thakore Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia Am J Psychiatry 160 2003 284 289
63. N.C. Andreasen, K. Rezai, R. Alliger, V.W. Swayze 2nd, M. Flaum, and P. Kirchner et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London Arch Gen Psychiatry 49 1992 943 958
64. R.G. Steen, R.M. Hamer, and J.A. Lieberman Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: A systematic review and meta-analysis Neuropsychopharmacology 30 2005 1949 1962
65. S. Prabakaran, J.E. Swatton, M.M. Ryan, S.J. Huffaker, J.T. Huang, and J.L. Griffin et al. Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress Mol Psychiatry 9 2004 684 697 643
66. C.R. Scriver, W.S. Sly, B. Childs, A.L. Beaudet, D. Valle, K.W. Kinzler, and B. Vogelstein The Metabolic and Molecular Bases of Inherited Disease 2000 McGraw-Hill Professional New York
67. H. Kaiya, A. Nishida, A. Imai, S. Nakashima, and Y. Nozawa Accumulation of diacylgylcerol in platelet phosphoinositide turnover in schizophrenia: A biological marker of good prognosis? Biol Psychiatry 26 1989 669 676
68. J. Yao, J.A. Stanley, R.D. Reddy, M.S. Keshavan, and J.W. Pettegrew Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites Biol Psychiatry 52 2002 823 830
69. E. Schwarz, S. Prabakaran, P. Whitfield, H. Major, F.M. Leweke, and D. Koethe et al. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides J Proteome Res 7 2008 4266 4277
70. M.P. Freeman, J.R. Hibbeln, K.L. Wisner, J.M. Davis, D. Mischoulon, and M. Peet et al. Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry J Clin Psychiatry 67 2006 1954 1967
71. P.M. Kidd Omega-3 DHA and EPA for cognition, behavior, and mood: Clinical findings and structural-functional synergies with cell membrane phospholipids Altern Med Rev 12 2007 207 227
72. M. Peet, D.F. Horrobin E-E Multicentre Study Group A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms J Psychiatr Res 36 2002 7 18
73. P. Katsel, K.L. Davis, C. Li, W. Tan, E. Greenstein, L.B. Kleiner Hoffman, and V. Haroutunian Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes Neuropsychopharmacology 33 2008 2993 3009
74. R.A. Shepherd, P.R. Bates, and J.J. McGrath Cell cycle characteristics and schizophrenia Biol Psychiatry 33 1993 60 61
75. L.F. Jarskog, E.S. Selinger, J.A. Lieberman, and J.H. Gilmore Apoptotic proteins in the temporal cortex in schizophrenia: High Bax/Bcl-2 ratio without caspase-3 activation Am J Psychiatry 161 2004 109 115
76. N.C. Allen, S. Bagade, M.B. McQueen, J.P. Ioannidis, F.K. Kavvoura, and M.J. Khoury et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database Nat Genet 40 2008 827 834
77. V.S. Catts, S.V. Catts, B.I. O'Toole, and A.D. Frost Cancer incidence in patients with schizophrenia and their first-degree relatives - a meta-analysis Acta Psychiatr Scand 117 2008 323 336
78. S. Mukherjee, S.P. Mahadik, D.B. Schnur, H. Laev, and R. Reddy Abnormal growth of cultured skin fibroblasts associated with poor premorbid history in schizophrenic patients Schizophr Res 13 1994 233 237
79. A.F. Terwisscha van Scheltinga, S.C. Bakker, and R.S. Kahn Fibroblast growth factors in schizophrenia Schizophr Bull 36 2010 1157 1166
80. W.W. Eaton, M. Byrne, H. Ewald, O. Mors, C.Y. Chen, E. Agerbo, and P.B. Mortensen Association of schizophrenia and autoimmune diseases: Linkage of Danish national registers Am J Psychiatry 163 2006 521 528
81. S.G. Schwab, J. Hallmayer, J. Freimann, B. Lerer, M. Albus, and M. Borrmann-Hassenbach et al. Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia Am J Med Genet 114 2002 315 320
82. L. Drzyzga, E. Obuchowicz, A. Marcinowska, and Z.S. Herman Cytokines in schizophrenia and the effects of antipsychotic drugs Brain Behav Immun 20 2006 532 545
83. S. Potvin, E. Stip, A.A. Sepehry, A. Gendron, R. Bah, and E. Kouassi Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review Biol Psychiatry 63 2008 801 808
84. K. Saijo, and C.K. Glass Microglial cell origin and phenotypes in health and disease Nat Rev Immunol 11 2011 775 787
85. E. Schwarz, R. Izmailov, M. Spain, A. Barnes, J.P. Mapes, and P.C. Guest et al. Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia Biomark Insights 5 2010 39 47
86. E. Schwarz, P.C. Guest, J. Steiner, B. Bogerts, and S. Bahn Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients Transl Psychiatry 2 2012 e82